Paper Title:
Anti-Tumor Immunotherapy Elicited by Cross-Link Peptide Vaccine Alpha-Fetoprotein and Heat Shock Protein 70 Complex
  Abstract

Purposes: To construct a recombinant vaccine alpha-fetoprotein (AFP)-heat shock protein (HSP70) complex, and study its ability to induce specific CTL response and its protective effect against AFP-producing tumor. Material/Methods: A recombinant vaccine was constructed by conjugating mouse alpha-fetoprotein to heat shock protein 70. By way of intracutaneous injection, mice were primed and boosted with recombinant vaccine mAFP/HSP70, whereas single mAFP or HSP70 injection as controls. The ELISPOT and ELISA were used to measure the frequency of cells producing the cytokine IFN-gama in splenocytes and the level of anti-AFP antibody of serum from immunized mice respectively. In vivo tumor challenges were carried out to assess the immune effect of the recombinant vaccine. Results: By recombinant mAFP/HSP70 vaccine immunization, the results of ELISPOT and ELISA showed that the number of splenic cells producing IFN-gama and the level of anti-AFP antibody of serum were significantly higher in mAFP/HSP70 group than those in mAFP and HSP70 groups (108.50±11.70 IFN-gama spots/106 cells vs 41.60±10.40 IFN-gama spots/106 cells, 7.32±3.14 IFN-gama spots/106 cells, P<0.01; 156.32±10.42 µg/mL vs 66.52±7.35 µg/mL, 5.73±2.89 µg/mL, P<0.01). The tumor volume in mAFP/HSP70 group was significantly smaller than that in mAFP and HSP70 groups (42.44±7.14 mm3 vs 392.23±12.46 mm3, 838.63±13.84 mm3, P<0.01). Conclusions: The study further confirmed the function of heat shock protein 70’s immune adjuvant. Sequential immunization with recombinant mAFP/HSP70 vaccine could generate effective antitumor immunity on AFP-producing tumor. The recombined mAFP/HSP70 vaccine may be suitable for serving as an immunotherapy for hepatocellular carcinoma.

  Info
Periodical
Advanced Materials Research (Volumes 343-344)
Chapter
Session 2: Materials for Biomedical Engineering Application
Edited by
David Wang
Pages
378-383
DOI
10.4028/www.scientific.net/AMR.343-344.378
Citation
H. P. Lin, X. P. Wang, Q. X. Wang, "Anti-Tumor Immunotherapy Elicited by Cross-Link Peptide Vaccine Alpha-Fetoprotein and Heat Shock Protein 70 Complex", Advanced Materials Research, Vols. 343-344, pp. 378-383, 2012
Online since
September 2011
Export
Price
$32.00
Share

In order to see related information, you need to Login.

In order to see related information, you need to Login.

Authors: Xiao Ping Wang, Huan Ping Lin, Qiao Xia Wang
Chapter 4: Biomedical Manufacturing
Abstract:Purposes: To construct a recombinant vaccine alpha-fetoprotein (AFP)-glycoprotein (gp96) complex, and study its ability to induce specific...
397
Authors: Thidarat Wangkam, Kitti Boonperm, Phatra Khomkrachang, Toemsak Srikhirin, Verayuth Praphanphoj, Boonsong Sutapan, Armote Somboonkaew, Ratthasart Amarit
Chapter 2: Nanomaterials and Nanotechnologies in Biomedical Application
Abstract:Hepatocellular carcinoma is a one of the most common cancer in the world and the third cause of cancer-related death. The recommended...
84